JP2021517909A5 - - Google Patents
Info
- Publication number
- JP2021517909A5 JP2021517909A5 JP2020568662A JP2020568662A JP2021517909A5 JP 2021517909 A5 JP2021517909 A5 JP 2021517909A5 JP 2020568662 A JP2020568662 A JP 2020568662A JP 2020568662 A JP2020568662 A JP 2020568662A JP 2021517909 A5 JP2021517909 A5 JP 2021517909A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- nucleotides
- length
- chain
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637973P | 2018-03-02 | 2018-03-02 | |
| US62/637,973 | 2018-03-02 | ||
| PCT/US2019/018184 WO2019168686A1 (en) | 2018-03-02 | 2019-02-15 | Methods and compositions for treating bile duct paucity-associated conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021517909A JP2021517909A (ja) | 2021-07-29 |
| JP2021517909A5 true JP2021517909A5 (https=) | 2022-02-17 |
| JPWO2019168686A5 JPWO2019168686A5 (https=) | 2022-02-17 |
Family
ID=67805109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568662A Pending JP2021517909A (ja) | 2018-03-02 | 2019-02-15 | 胆管減少症関連状態を治療するための方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11634715B2 (https=) |
| EP (1) | EP3740248A4 (https=) |
| JP (1) | JP2021517909A (https=) |
| KR (1) | KR20200127008A (https=) |
| CN (1) | CN112055597A (https=) |
| AU (1) | AU2019228448A1 (https=) |
| CA (1) | CA3092089A1 (https=) |
| IL (1) | IL277015A (https=) |
| MX (1) | MX2020009074A (https=) |
| WO (1) | WO2019168686A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3092089A1 (en) | 2018-03-02 | 2019-09-06 | Dicerna Pharmaceuticals, Inc. | Methods and compositions for treating bile duct paucity-associated conditions |
| WO2024262593A1 (ja) * | 2023-06-22 | 2024-12-26 | 公益財団法人川崎市産業振興財団 | 核酸の血中安定性を向上させ、標的化効率を向上させる方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3037538T3 (da) | 2010-07-06 | 2019-06-24 | Dicerna Pharmaceuticals Inc | Fremgangsmåder og sammensætninger til specifik inhibering af beta-catenin ved hjælp af dobbeltstrenget rna |
| US9468670B2 (en) * | 2011-04-01 | 2016-10-18 | Texas A&M University System | Melatonin-based treatment and diagnosis of bile duct disease |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| AU2015330670B2 (en) * | 2014-10-10 | 2022-01-06 | Novo Nordisk Health Care Ag | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
| CA3092089A1 (en) | 2018-03-02 | 2019-09-06 | Dicerna Pharmaceuticals, Inc. | Methods and compositions for treating bile duct paucity-associated conditions |
-
2019
- 2019-02-15 CA CA3092089A patent/CA3092089A1/en active Pending
- 2019-02-15 US US16/975,946 patent/US11634715B2/en active Active
- 2019-02-15 AU AU2019228448A patent/AU2019228448A1/en not_active Abandoned
- 2019-02-15 WO PCT/US2019/018184 patent/WO2019168686A1/en not_active Ceased
- 2019-02-15 JP JP2020568662A patent/JP2021517909A/ja active Pending
- 2019-02-15 MX MX2020009074A patent/MX2020009074A/es unknown
- 2019-02-15 KR KR1020207027733A patent/KR20200127008A/ko not_active Ceased
- 2019-02-15 CN CN201980029432.6A patent/CN112055597A/zh active Pending
- 2019-02-15 EP EP19761345.8A patent/EP3740248A4/en not_active Withdrawn
-
2020
- 2020-08-31 IL IL277015A patent/IL277015A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521796A5 (https=) | ||
| JP2021511042A5 (https=) | ||
| JP2019214587A5 (https=) | ||
| JP2020529197A5 (https=) | ||
| JPWO2019204021A5 (https=) | ||
| JP2021507686A5 (https=) | ||
| JP2024081668A5 (https=) | ||
| RU2006126643A (ru) | Олигомерные соединения для модуляции bcl-2 | |
| JP2018150344A5 (https=) | ||
| JP2021533762A5 (https=) | ||
| JP2004513626A5 (https=) | ||
| JP2018516091A5 (https=) | ||
| JP2009514877A5 (https=) | ||
| JP2021529173A5 (https=) | ||
| JP2021517909A5 (https=) | ||
| CN113795582A (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| JP2003520811A5 (https=) | ||
| JP2021517826A5 (https=) | ||
| JPWO2022032288A5 (https=) | ||
| CN115698288A (zh) | 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途 | |
| JPWO2019193144A5 (https=) | ||
| JPWO2021188795A5 (https=) | ||
| JPWO2019143621A5 (https=) | ||
| KR950700408A (ko) | 인접한 촉진제 올리고누클레오티드에 의한 리보자임 촉매활성의 증강(enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide) | |
| CN115702006A (zh) | 缀合基团及其缀合物 |